Wave Life Sciences (WVE) Current Assets (2014 - 2026)
Wave Life Sciences posted quarterly Current Assets of $561.3 million for Q1 2026, up 117.57% year-on-year from $258.0 million in Q1 2025, and down 8.71% on a QoQ basis from $614.8 million in Q4 2025.
Wave Life Sciences (WVE) has 13 years of Current Assets data on file, last reported at $561.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 117.57% year-over-year to $561.3 million; the trailing twelve-month figure through Mar 2026 stood at $561.3 million (up 117.57% YoY), and the FY2025 full-year result was $614.8 million, up 91.89% from the prior year.
- Current Assets for Q1 2026 stood at $561.3 million, down from $614.8 million in the prior quarter.
- Across five years, Current Assets topped out at $614.8 million in Q4 2025 and bottomed at $98.5 million in Q4 2022.
- The 5-year median for Current Assets is $215.5 million (2025), against an average of $247.0 million.
- The widest annual swing landed in 2022, when Current Assets tumbled 39.39%; it then surged 138.87% in 2023.
- A 5-year view of Current Assets shows it stood at $98.5 million in 2022, then soared by 138.87% to $235.4 million in 2023, then soared by 36.12% to $320.4 million in 2024, then jumped by 91.89% to $614.8 million in 2025, then dropped by 8.71% to $561.3 million in 2026.
- The last three Current Assets figures came in at $561.3 million (Q1 2026), $614.8 million (Q4 2025), and $215.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | 561.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 561.27 Mn |
| Dec 31, 2025 | 614.81 Mn |
| Sep 30, 2025 | 215.49 Mn |
| Jun 30, 2025 | 223.56 Mn |
| Mar 31, 2025 | 257.98 Mn |
| Dec 31, 2024 | 320.39 Mn |
| Sep 30, 2024 | 324.52 Mn |
| Jun 30, 2024 | 172.08 Mn |
| Mar 31, 2024 | 196.77 Mn |
| Dec 31, 2023 | 235.37 Mn |
| Sep 30, 2023 | 158.57 Mn |
| Jun 30, 2023 | 184.71 Mn |
| Mar 31, 2023 | 219.59 Mn |
| Dec 31, 2022 | 98.54 Mn |
| Sep 30, 2022 | 131.43 Mn |
| Jun 30, 2022 | 160.11 Mn |
| Mar 31, 2022 | 124.38 Mn |
| Dec 31, 2021 | 162.56 Mn |
| Sep 30, 2021 | 157.99 Mn |
| Jun 30, 2021 | 159.43 Mn |
| Mar 31, 2021 | 194.55 Mn |
| Dec 31, 2020 | 230.04 Mn |
| Sep 30, 2020 | 258.43 Mn |
| Jun 30, 2020 | 146.83 Mn |
| Mar 31, 2020 | 149.79 Mn |
| Dec 31, 2019 | 185.48 Mn |
| Sep 30, 2019 | 250.26 Mn |
| Jun 30, 2019 | 289.59 Mn |
| Mar 31, 2019 | 315.03 Mn |
| Dec 31, 2018 | 202.27 Mn |
| Sep 30, 2018 | 233.16 Mn |
| Jun 30, 2018 | 267.67 Mn |
| Mar 31, 2018 | 117.96 Mn |
| Dec 31, 2017 | 150.49 Mn |
| Sep 30, 2017 | 173.83 Mn |
| Jun 30, 2017 | 201.22 Mn |
| Mar 31, 2017 | 132.78 Mn |
| Dec 31, 2016 | 151.99 Mn |
| Sep 30, 2016 | 172.14 Mn |
| Jun 30, 2016 | 183.94 Mn |
| Mar 31, 2016 | 154.00 Mn |
| Dec 31, 2015 | 161.38 Mn |
| Sep 30, 2015 | 67.99 Mn |
| Dec 31, 2014 | 1.49 Mn |